(L) Loblaw Companies - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA5394811015

L: Grocery, Pharmacy, Health, Apparel, Merchandise

Loblaw Companies Limited, a leading Canadian food and pharmacy retailer, operates a diverse portfolio of businesses spanning grocery, pharmacy, health and beauty products, apparel, general merchandise, financial services, and wireless communications. Through its Retail and Financial Services segments, the company serves millions of Canadians daily. The Retail segment encompasses corporate and franchise-owned food stores, associate-owned pharmacies, and a range of specialty stores offering health and beauty products, apparel, and general merchandise. The Financial Services segment provides credit card and banking services, the PC Optimum loyalty program, insurance brokerage, and telecommunication services. Loblaw also offers a suite of healthcare services, including the PC Health app, specialty drug distribution, long-term care services, and wellness programs. Its brands include Presidents Choice, Life Brand, no name, Farmers Market, Joe Fresh, No Frills, Maxi, Loblaws, Zehrs, Shoppers Drug Mart, and Pharmaprix. The company, founded in 1919 and headquartered in Brampton, Canada, is a subsidiary of George Weston Limited.

Over the next three months, Loblaw Companies Limited (TO:L) is expected to maintain its upward momentum, supported by strong fundamentals and improving technical indicators. The stock has shown consistent growth, with its 20-day SMA crossing above the 50-day SMA, signaling a bullish trend. The current price of $213.68 is well above the 200-day SMA of $180.37, indicating long-term strength. The ATR of 4.81 suggests moderate volatility, with potential for further gains as the company continues to expand its healthcare offerings and loyalty programs. With a forward P/E of 22.17 and a P/S ratio of 1.03, Loblaw is well-positioned to capitalize on its market leadership in food retail and pharmacy services. Investors should monitor the stocks ability to break above resistance levels and maintain its upward trajectory.

Additional Sources for L Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

L Stock Overview

Market Cap in USD 48,463m
Sector Consumer Defensive
Industry Grocery Stores
GiC Sub-Industry Food Retail
IPO / Inception

L Stock Ratings

Growth Rating 93.2
Fundamental 57.3
Dividend Rating 38.5
Rel. Strength 29.3
Analysts -
Fair Price Momentum 265.92 CAD
Fair Price DCF 268.34 CAD

L Dividends

Dividend Yield 12m 1.12%
Yield on Cost 5y 3.39%
Annual Growth 5y 7.62%
Payout Consistency 33.2%

L Growth Ratios

Growth Correlation 3m 97%
Growth Correlation 12m 93.2%
Growth Correlation 5y 97%
CAGR 5y 27.42%
CAGR/Max DD 5y 1.99
Sharpe Ratio 12m 2.43
Alpha 38.19
Beta 0.181
Volatility 19.26%
Current Volume 661.2k
Average Volume 20d 310.4k
What is the price of L stocks?
As of May 09, 2025, the stock is trading at CAD 220.60 with a total of 661,191 shares traded.
Over the past week, the price has changed by -1.45%, over one month by +11.37%, over three months by +24.17% and over the past year by +42.52%.
Is Loblaw Companies a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Loblaw Companies (TO:L) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 57.26 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of L as of May 2025 is 265.92. This means that L is currently undervalued and has a potential upside of +20.54% (Margin of Safety).
Is L a buy, sell or hold?
Loblaw Companies has no consensus analysts rating.
What are the forecast for L stock price target?
According to ValueRays Forecast Model, L Loblaw Companies will be worth about 287.2 in May 2026. The stock is currently trading at 220.60. This means that the stock has a potential upside of +30.19%.
Issuer Forecast Upside
Wallstreet Target Price 223 1.1%
Analysts Target Price - -
ValueRay Target Price 287.2 30.2%